These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 28755324

  • 1. Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.
    Henker C, Kriesen T, Glass Ä, Schneider B, Piek J.
    J Neurooncol; 2017 Nov; 135(2):391-402. PubMed ID: 28755324
    [Abstract] [Full Text] [Related]

  • 2. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
    Yan JL, van der Hoorn A, Larkin TJ, Boonzaier NR, Matys T, Price SJ.
    J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
    De Barros A, Attal J, Roques M, Nicolau J, Sol JC, Charni S, Cohen-Jonathan-Moyal E, Roux FE.
    Clin Neurol Neurosurg; 2020 Sep; 196():105972. PubMed ID: 32512407
    [Abstract] [Full Text] [Related]

  • 9. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
    Auer TA, Della Seta M, Collettini F, Chapiro J, Zschaeck S, Ghadjar P, Badakhshi H, Florange J, Hamm B, Budach V, Kaul D.
    Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
    [Abstract] [Full Text] [Related]

  • 10. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [Abstract] [Full Text] [Related]

  • 11. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
    Gramatzki D, Kickingereder P, Hentschel B, Felsberg J, Herrlinger U, Schackert G, Tonn JC, Westphal M, Sabel M, Schlegel U, Wick W, Pietsch T, Reifenberger G, Loeffler M, Bendszus M, Weller M.
    Neurology; 2017 Apr 11; 88(15):1422-1430. PubMed ID: 28298550
    [Abstract] [Full Text] [Related]

  • 12. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
    Saito T, Muragaki Y, Maruyama T, Komori T, Nitta M, Tsuzuki S, Fukui A, Kawamata T.
    Neurosurg Rev; 2020 Dec 11; 43(6):1583-1593. PubMed ID: 31705405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glioblastoma in the elderly.
    Chamberlain MC.
    Cancer Treat Res; 2015 Dec 11; 163():159-70. PubMed ID: 25468231
    [Abstract] [Full Text] [Related]

  • 16. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
    Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR.
    Neuroimage; 2010 Jan 15; 49(2):1398-405. PubMed ID: 19796694
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
    Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, Harosh CB, Ram Z.
    Ann Surg Oncol; 2017 Mar 15; 24(3):794-800. PubMed ID: 27766560
    [Abstract] [Full Text] [Related]

  • 18. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
    Rapp M, Goeppert M, Felsberg J, Steiger HJ, Sabel M.
    Br J Neurosurg; 2013 Aug 15; 27(4):430-5. PubMed ID: 23418781
    [Abstract] [Full Text] [Related]

  • 19. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
    Salvati M, Pichierri A, Piccirilli M, Floriana Brunetto GM, D'Elia A, Artizzu S, Santoro F, Arcella A, Giangaspero F, Frati A, Simione L, Santoro A.
    J Neurosurg; 2012 Aug 15; 117(2):204-11. PubMed ID: 22655594
    [Abstract] [Full Text] [Related]

  • 20. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A, Muragaki Y, Saito T, Maruyama T, Nitta M, Ikuta S, Kawamata T.
    World Neurosurg; 2017 Feb 15; 98():73-80. PubMed ID: 27989974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.